assets
Recursion’s homegrown assets hardest hit in AI-discovered pipeline cull
Recursion, homegrown, assets
Newleos Therapeutics Launches with $93.5M to Advance Novel Neuropsychiatric Treatments
Newleos Therapeutics, mental health, neuropsychiatry, Roche assets, Series A funding, anxiety disorders, substance use disorders, GABA modulators